Medication of the hypoglycaemic effect of 5-hydroxytryptophan by a central nervous system action.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles / Q000187:drug effects; D002698:Chloralose / Q000494:pharmacology; D007267:Injections; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D008954:Models, Biological; D009526:Nialamide / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D014520:Urethane / Q000494:pharmacology
D001786:Blood Glucose; D002698:Chloralose; D012701:Serotonin; D014520:Urethane; D006916:5-Hydroxytryptophan; D010424:Pentobarbital; D009526:Nialamide